Bionorica, one of the world’s leading manufacturers of scientifically researched herbal medicines is a premier supplier for the phytomedicine market in Russia. All new medications released must comply with Russia’s Federal Law No. 425-FZ (Chestny ZNAK), which dictates the requirements of drug serialization that manufacturers must meet. Chestny ZNAK is a national track and trace system created by the Centre for Research in Perspective Technologies (CRPT) in Russia.
Bionorica required a solution that established a direct connection to the Russian Order Management System and automated the reporting process while taking its needs as a global manufacturer of herbal medicines into account. By using Movilitas.Cloud for monitoring and the legal reporting of all transactions, a direct integration from Bionorica’s SAP Advanced Track and Trace for Pharmaceuticals (SAP ATTP) solution to the Russian MDLP system was created.
In this case study, which was originally posted in the GS1 Healthcare Reference book, GS1 and Movilitas provide an overview of Chestny ZNAK and Bionorica's transition to handling complex serialization requirements for full compliance.
Originally published on GS1